ArticleThe Journal of international medical research2016

Remission and low disease activity in a cohort of real-life patients with rheumatoid arthritis treated with first-line antitumour necrosis factor.

Paola Conigliaro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.